Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

risedronate sodium 30 MG Oral Tablet

Known as: RISEDRONATE SODIUM HEMI-PENTAHYDRATE 25.8 mg / RISEDRONATE SODIUM MONOHYDRATE 4.2 mg ORAL TABLET, FILM COATED, RISEDRONATE SODIUM HEMI-PENTAHYDRATE 30 mg ORAL TABLET, FILM COATED, RISEDRONATE NA 30MG TAB [VA Product] 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Highlights • A “drug holiday” can be considered for patients at low fracture risk• It is optimal after completion of five years… Expand
2015
2015
Abstract The purpose of this work is to prepare a self-microemulsifying drug delivery system (SMEDDS) for risedronate sodium (RSD… Expand
2015
2015
Bisphosphonates can cause chemical ulcerations in the esophagus in some patients. The postulated pathophysiological mechanism of… Expand
2006
2006
L'invention concerne une nouvelle methode de preparation de risedronate sodique cristallin, mise en oeuvre dans des conditions… Expand
Review
2003
Review
2003
Abstract▴ Risedronate (risedronic acid), an orally administered pyridinyl bisphosphonate, inhibits osteoclast-mediated resorption… Expand